Treatment Selection and Sequencing Strategies in HER2+ Metastatic Breast Cancer : Episode 5

Treatment Goals, Side Effects, and Supportive Care Strategies for Patients and Caregivers with HER2+ BC

March 24, 2025

Opinion

Video

Experts discuss how, discuss patient experiences with an oral chemotherapy regimen, highlighting benefits like treatment autonomy, challenges such as pill burden and gastrointestinal toxicities, and the importance of proactive side effect management and patient education.

EP: 1.Treatment Selection and Sequencing in Third Line Settings and Beyond

EP: 2.Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options

EP: 3.Managing Toxicity in Later-Line HER2+ mBC Treatments: Real-World Insights and Mitigation Strategies for Optimal Patient QOLs

EP: 4.Supporting HER2+ mBC Patients in Later Lines: AE Management and the Role of the Multidisciplinary Team

Now Viewing

EP: 5.Treatment Goals, Side Effects, and Supportive Care Strategies for Patients and Caregivers with HER2+ BC

EP: 6.Barbara's Story: Navigating HER2+ MBC with Brain Metastases & Tucatinib-Based Treatment in the Second-Line Setting

EP: 7.Evolving Treatment Strategies in Early HER2+ Breast Cancer

EP: 8.Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine

EP: 9.Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

Video content above is prompted by the following:

What has been your experience with oral regimens and managing toxicities and getting women acclimated to it?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!